| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/10/2002 | EP1195158A1 Sprayable pharmaceutical compositions and device |
| 04/10/2002 | EP1194584A1 Method for producing oligopolysaccharides |
| 04/10/2002 | EP1194568A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
| 04/10/2002 | EP1194567A1 Production of complex carbohydrates |
| 04/10/2002 | EP1194556A1 Methods and compositions for preventing the formation of aberrant rna during transcription of a plasmid sequence |
| 04/10/2002 | EP1194549A2 Human genes and gene expression products |
| 04/10/2002 | EP1194547A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 04/10/2002 | EP1194546A1 Compositions corresponding to a calcium transporter and methods of making and using same |
| 04/10/2002 | EP1194543A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 04/10/2002 | EP1194449A2 Inhibitors of memapsin 2 and use thereof |
| 04/10/2002 | EP1194448A1 Seven transmembrane receptor genes |
| 04/10/2002 | EP1194447A2 Novel potassium channels and genes encoding these potassium channels |
| 04/10/2002 | EP1194443A1 Cysteinyl protease inhibitors |
| 04/10/2002 | EP1194441A2 Thiophene a2a receptor agonists |
| 04/10/2002 | EP1194436A1 Sulfonamidomethyl phosphonate inhibitors of beta-lactamase |
| 04/10/2002 | EP1194430A1 Novel process |
| 04/10/2002 | EP1194429A1 Potassium channel openers |
| 04/10/2002 | EP1194427A1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv |
| 04/10/2002 | EP1194426A2 Benzofurane derivatives |
| 04/10/2002 | EP1194425A1 Substituted benzimidazole |
| 04/10/2002 | EP1194422A1 Biaryl compounds |
| 04/10/2002 | EP1194421A1 Selective npy (y5) antagonists |
| 04/10/2002 | EP1194418A1 Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof |
| 04/10/2002 | EP1194416A1 Halopyrimidines |
| 04/10/2002 | EP1194415A2 Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for their preparation |
| 04/10/2002 | EP1194411A1 Benzoylpyridazines |
| 04/10/2002 | EP1194410A1 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 04/10/2002 | EP1194409A1 Pyrazolidinol compounds |
| 04/10/2002 | EP1194406A1 Phenetyl-thiourea compounds for treating hiv infections |
| 04/10/2002 | EP1194405A1 Sulfur-containing thyroxane derivatives and their use as hair growth promotors |
| 04/10/2002 | EP1194404A1 Inhibitors of aspartyl protease |
| 04/10/2002 | EP1194403A1 Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same |
| 04/10/2002 | EP1194401A1 Diacylhydrazine derivatives |
| 04/10/2002 | EP1194186A2 CARDIOACTIVE COMPOSITION COMPRISING L-CARNITINE AND ITS DERIVATIVES AND i CRATAEGUS /i EXTRACTS |
| 04/10/2002 | EP1194173A1 X-ray guided drug delivery |
| 04/10/2002 | EP1194169A1 Stabilized vitamin c formulations |
| 04/10/2002 | EP1194168A2 Methods and products for manipulating uncoupling protein expression |
| 04/10/2002 | EP1194167A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 04/10/2002 | EP1194156A1 Method of treating malignancies and viral infections and improving immune function with a dietary supplement |
| 04/10/2002 | EP1194155A1 Synergistic compositions containing lycopene and silymarin for treatment of liver disease |
| 04/10/2002 | EP1194153A1 Taste masked pharmaceutical liquid formulations |
| 04/10/2002 | EP1194152A1 Src kinase inhibitor compounds |
| 04/10/2002 | EP1194151A1 Integrin receptor antagonists |
| 04/10/2002 | EP1194150A1 Use of nitroxides in wound healing and in the prevention of photodamage |
| 04/10/2002 | EP1194149A1 Cyclohexenyl-ethyl-thiourea compounds and use |
| 04/10/2002 | EP1194148A2 Cystic fibrosis medicaments |
| 04/10/2002 | EP1194147A1 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 04/10/2002 | EP1194146A1 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 04/10/2002 | EP1194145A2 Stable xylometazoline and oxymetazoline solution |
| 04/10/2002 | EP1194144A1 Antibacterial compounds |
| 04/10/2002 | EP1194143A2 Il-8 receptor antagonists |
| 04/10/2002 | EP1194142A1 Salts of cis -4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl) cyclohexan-1-carboxylate! |
| 04/10/2002 | EP1194141A1 Antiviral therapy |
| 04/10/2002 | EP1194140A1 Pharmaceutical composition containing fenofibrate and preparation method |
| 04/10/2002 | EP1194139A1 Nutritional composition for weight management |
| 04/10/2002 | EP1194138A1 Nutritional supplements |
| 04/10/2002 | EP1194137A2 Naphthoquinone derivatives and their use in the treatment and control of tuberculosis |
| 04/10/2002 | EP1194136A1 Non-solid composition for local application |
| 04/10/2002 | EP1194135A2 Methods of treating fungal infections with inhibitors of nad synthetase enzyme |
| 04/10/2002 | EP1194134A1 Transdermal therapeutic system for the utilization of tolterodine |
| 04/10/2002 | EP1194132A2 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| 04/10/2002 | EP1194129A1 Self-emulsifying systems containing anticancer medicament |
| 04/10/2002 | EP1194123A2 Method for controlled production of ultrafine microparticles and nanoparticles |
| 04/10/2002 | EP1194122A1 Methods for preparation of lipid-encapsulated therapeutic agents |
| 04/10/2002 | EP1194121A1 Steroid solution aerosol products with enhanced chemical stability |
| 04/10/2002 | EP1194115A1 Topically applied idebenone-containing agent with protective and regenerative effect |
| 04/10/2002 | EP1194109A1 Topical formulations comprising skin penetration agents and the use thereof |
| 04/10/2002 | EP1194044A1 Novel pharmaceutical or dietetic mushroom-based compositions |
| 04/10/2002 | EP1089719B1 Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 04/10/2002 | EP1087986B1 7.alpha.-methyl 19-nortestosterone undecanoate with androgenic activity |
| 04/10/2002 | EP1087662B1 Composition for keeping away vermin |
| 04/10/2002 | EP1051159B1 Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis |
| 04/10/2002 | EP1042323B1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them |
| 04/10/2002 | EP1030845B1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 04/10/2002 | EP1021178A4 Selenophene anti-tumor agents |
| 04/10/2002 | EP1021172B1 Dosage form for aerosol administration |
| 04/10/2002 | EP1015447B1 Piperidinylmethyloxazolidinone derivative |
| 04/10/2002 | EP0948478B1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
| 04/10/2002 | EP0937063B1 Aryloxypropanolamine derivatives, method of preparation and applications thereof |
| 04/10/2002 | EP0936911B1 Adenosine deaminase inhibitors |
| 04/10/2002 | EP0935458B1 Compositions containing at least one nucleic acid |
| 04/10/2002 | EP0930885B1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
| 04/10/2002 | EP0927150B1 Lipoxin compounds and their use in treating cell proliferative disorders |
| 04/10/2002 | EP0918774B9 Androgen receptor modulator compounds and methods |
| 04/10/2002 | EP0918510B1 Bioadhesive complexes of polycarbophil and azole antifungal or antiprotozoal drugs |
| 04/10/2002 | EP0912567B1 Carboline derivatives |
| 04/10/2002 | EP0901499B1 Adenosine derivatives |
| 04/10/2002 | EP0874842B1 Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) |
| 04/10/2002 | EP0863916B1 Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 04/10/2002 | EP0861067B1 Unit galenical form for local hormonotherapy of vaginal dryness |
| 04/10/2002 | EP0833642B1 Compressed dry-granulation desogestrel tablets |
| 04/10/2002 | EP0813535B1 Hexacyclic camptothecin analogues, and process for preparing them |
| 04/10/2002 | EP0807434B1 Anti-inflammatory eyedrops |
| 04/10/2002 | EP0805815B1 Use of bismuth compounds for the manufacture of medicaments for the treatment of gastric disorders caused by Helicobacter pylori |
| 04/10/2002 | EP0788383B1 Modulation of cell proliferation and wound healing |
| 04/10/2002 | EP0771191B1 Immunological activity of rhamnolipids |
| 04/10/2002 | EP0768866B1 Desquamation compositions |
| 04/10/2002 | EP0764032B1 Stable gel formulation for topical treatment of skin conditions |
| 04/10/2002 | EP0739351B1 Monomeric diols and phosphate linked oligomers formed therefrom |
| 04/10/2002 | EP0739338B1 serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide |